These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15366675)

  • 1. [Esophageal complications of non steroidal antiinflammatory drugs].
    Bigard MA; Pelletier AL
    Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C58-61. PubMed ID: 15366675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NSAID administration and esophageal pathology: interaction with gastroesophageal reflux disease (GERD) symptoms, risk factors and incidence of erosive esophagitis].
    Karateev AE; Uspenskiĭ IuP; Pakhomova IG; Nasonov EL
    Eksp Klin Gastroenterol; 2008; (3):11-6. PubMed ID: 19145877
    [No Abstract]   [Full Text] [Related]  

  • 3. Esophageal motility and intraesophageal pH patterns in patients with esophagitis and chronic nonsteroidal anti-inflammatory drug use.
    Sopeña F; Lanas A; Sáinz R
    J Clin Gastroenterol; 1998 Dec; 27(4):316-20. PubMed ID: 9855260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAIDs, aspirin, and esophageal strictures: are over-the-counter medications harmful to the esophagus?
    Kim SL; Hunter JG; Wo JM; Davis LP; Waring JP
    J Clin Gastroenterol; 1999 Jul; 29(1):32-4. PubMed ID: 10405227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study.
    Ruszniewski P; Soufflet C; Barthélémy P
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1134-9. PubMed ID: 18671778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs.
    El-Serag HB; Sonnenberg A
    Am J Gastroenterol; 1997 Jan; 92(1):52-6. PubMed ID: 8995937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for erosive reflux esophagitis: a case-control study.
    Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
    Am J Gastroenterol; 2001 Jan; 96(1):41-6. PubMed ID: 11197285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are dyspepsia or gastroesophageal reflux predictive of serious digestive events during treatment with NSAIDs? How should they be treated?].
    Abitbol V; Chaussade S
    Presse Med; 2003 Nov; 32(37 Pt 2):S53-5. PubMed ID: 14763356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of naproxen on gastroesophageal reflux and esophageal function: a randomized, double-blind, placebo-controlled study.
    Scheiman JM; Patel PM; Henson EK; Nostrant TT
    Am J Gastroenterol; 1995 May; 90(5):754-7. PubMed ID: 7733082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of gastroesophageal reflux disease with esophageal injury in korean: focusing on risk factors].
    Lee SJ; Jung MK; Kim SK; Jang BI; Lee SH; Kim KO; Kim ES; Cho KB; Park KS; Kim EY; Jung JT; Kwon JG; Lee JH; Yang CH; Park CK; Seo HE; Jeon SW
    Korean J Gastroenterol; 2011 May; 57(5):281-7. PubMed ID: 21623136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid reflux is a poor predictor for severity of erosive reflux esophagitis.
    Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
    Dig Dis Sci; 2002 Nov; 47(11):2565-73. PubMed ID: 12452396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the real impairment on esophageal motility in patients with gastroesophageal reflux disease?
    Falcão A; Nasi A; Brandão J; Sallum R; Cecconello I
    Arq Gastroenterol; 2013 Apr; 50(2):111-6. PubMed ID: 23903620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
    Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
    Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of drugs on the esophagus.
    Tutuian R;
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):91-7. PubMed ID: 20227023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healing of severe reflux esophagitis with PPI does not improve esophageal dysmotility.
    Xu JY; Xie XP; Song GQ; Hou XH
    Dis Esophagus; 2007; 20(4):346-52. PubMed ID: 17617885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.